Loading…
Kevin R Sayer is Executive Chair at Dexcom. OQRO lists 10 transactions filed with the SEC under this name, the latest on Aug 24, 2026, each linked to the official Form 4.
Executive Chair
Disclosures on record
10
Companies involved
1
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.